Pharma C Investments - Publication of Circular and Notice of GM
Announcement provided by
Pitch Pit plc · PICH27/11/2023 07:00
27 November 2023
Pharma C Investments PLC
("Pharma C" or the "Company")
Publication of Circular and Notice of General Meeting
Pharma C (AQSE: PCIL) announces that a general meeting of the Company ("GM") will be held at 11 am on 11 December 2023 at the offices of Hill Dickinson LLP, The Broadgate Tower, 20 Primrose St,
The purpose of the General Meeting is to propose four resolutions that require shareholder approval.
Ordinary resolutions
Resolution 1: amend the Company's investment policy to allow the Company to consider investments or businesses in the technology, fintech and AI sectors;
Resolution 2: the Directors be generally and unconditionally authorised to exercise all the powers of the Company to allot new ordinary shares of
Special resolutions
Resolution 3: that each existing ordinary share of
Resolution 4: that conditional upon the passing of Resolutions 2 and 3, the Directors be empowered to allot equity securities for cash pursuant to the authority conferred by Resolution 2 above as if section 561 of the Companies Act and any pre-emption rights in the Articles did not apply to such allotment.
The Directors of Pharma C take responsibility for this announcement.
For further information please visit www.pharmacinvestments.com
Pharma C Investments |
|
Gavin Sathianathan, Investment Strategy Director |
|
First Sentinel Corporate Finance |
|
Brian Stockbridge, Corporate Adviser |
+44 20 3855 5551 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.